Cargando…
Estrogenic in vitro evaluation of zearalenone and its phase I and II metabolites in combination with soy isoflavones
Humans and animals are exposed to multiple substances in their food and feed that might have a negative health impact. Among these substances, the Fusarium mycoestrogen zearalenone (ZEN) and its metabolites α-zearalenol (α-ZEL) and α-zearalanol (α-ZAL) are known to possess endocrine disruptive prope...
Autores principales: | Grgic, Dino, Betschler, Andrea, Früholz, Rebeka, Novak, Barbara, Varga, Elisabeth, Marko, Doris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584851/ https://www.ncbi.nlm.nih.gov/pubmed/35986755 http://dx.doi.org/10.1007/s00204-022-03358-3 |
Ejemplares similares
-
Isoflavones in Animals: Metabolism and Effects in Livestock and Occurrence in Feed
por: Grgic, Dino, et al.
Publicado: (2021) -
Goitrogenic and estrogenic activity of soy isoflavones.
por: Doerge, Daniel R, et al.
Publicado: (2002) -
Biotransformation of the Mycotoxin Zearalenone to its Metabolites Hydrolyzed Zearalenone (HZEN) and Decarboxylated Hydrolyzed Zearalenone (DHZEN) Diminishes its Estrogenicity In Vitro and In Vivo
por: Fruhauf, Sebastian, et al.
Publicado: (2019) -
Soy isoflavones, estrogen therapy, and breast cancer risk: analysis and commentary
por: Messina, Mark J, et al.
Publicado: (2008) -
Soy isoflavones and virus infections
por: Andres, Aline, et al.
Publicado: (2009)